Table 2.
Oligonucleotides Used in the Study.
Purpose | GB# of the target | Sequence |
orf for ‘antisense’ constructs | AY547446 (UP9C) | 5′-CGGGATCCATGTTTTCGACAATTGCT-3’ |
5′-GCAAGCTTGGTACCTCATTGGGAACTGGGAAC-3’ | ||
orf for UP9C–EYFP fusion | AY547446 (UP9C) | 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGTTTTCGACAATTGCTGT-3’ |
5′-GGGGACCACTTTGTACAAGAAAGCTGGGTCTTGGGAACTGGGAACGGTAA-3’ | ||
orf for Y2H | AY547446 (UP9C) | 5′-CGGAATTCTTTTCGACAATTGCTGTGC-3’ |
5′-GCCTGCAGAGCGTCAAACTCCATTACCC-3’ | ||
sqRT–PCR | DQ444223 (UP9A) | 5′-ACCACAAATCAATCTCCTACCT-3’ |
5′-ACGTGCTCTACCTAGTTTGAA-3’ | ||
AY547446 (UP9C) | 5′-ACCACAAATCAGTTTCCTGCATT-3’ | |
5′-ACGTGCTCTACCTAGTTTGAA-3’ | ||
FG638291 (UP9B) | 5′-TCAACTACTACTATTTCCTTCAACATG-3’ | |
5′-ACCTCCATTAATCCGAGTGCCTAA-3’ | ||
FG636997 (UP9D) | 5′-TGCCTCAGTTTTAATAGTAGCAATTTT-3’ | |
5′-AATACAAACAGGCCGCCACCAA-3’ | ||
X69885 (Tac9) | 5′-CCTCCCACATGCTATTCTCC-3’ | |
5′-AGAGCCTCCAATCCAGACAC-3’ | ||
qRT-PCR | X69885 (Tac9) | 5′-GTGTCTGGATTGGAGGCTCT-3’ |
5′-ATGAAGCAAACCTGCTGGAA-3’ | ||
DQ138111 (UBQ2) | 5′-AGGTTGATGATTCCGGTAAGG-3’ | |
5′-CACACTCAGCATTGGGACAC-3’ | ||
AY648056 (APR) | 5′-TTCCCTGACGCTGTTGAAG-3’ | |
5′-CCACCACCATCTTCCCTCT-3’ | ||
AJ745720 (ST) | 5′-CCATTATCCTCTCGACGTTA-3’ | |
5′-TCAAACCAGAAATTGCACCA-3’ | ||
AF321137 (ADC) | 5′-TGGAGGTGGGCTTGGAATT-3’ | |
5′-TGAACAACTGCGGAGGCAT-3’ | ||
AF127242 (ODC) | 5′-TGATTGGCTGGTTTTTCCTAA-3’ | |
5′-AGGTGGTTCATCAGCTTGGA-3’ | ||
U91924 (SAMD) | 5′-TGGCAAGGGTGGTTCCAT-3’ | |
5′-TCTTTCCAGCAGCCCTTCA-3’ | ||
AY445582 (SAMS) | 5′-ACCGGATGGCAAGACACAAG-3’ | |
5′-TCCTGGGCGATCTGCTCA-3’ | ||
D90196 (PR1a) | 5′-AGTCATGGGATTTGTTCTCTT-3’ | |
5′-ACGGCAAGAGTGGGATATTA-3’ | ||
X66942 (PR1b) | 5′-TTGGTGGTATTATGGAGGTGTG-3’ | |
5′-ACTGCCGTTGACTCATCACCT-3’ | ||
D38123 (ERF1) | 5′-TAGGGGAAGGCATTACAGAG-3’ | |
5′-TCGTATGTTCCAAGCCAAA-3’ |